ArticleCMAJ open
Determinants of SARS-CoV-2 vaccine willingness among people incarcerated in 3 Canadian federal prisons: a cross-sectional study.
Abstract read
In one paragraph
Article in CMAJ open. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 1 of them a synthesis that pooled it.
0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 1 pooled it
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
6 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Bidirectional associations between influenza and COVID-19 vaccination: a systematic review and meta-analysis.Frontiers in public health · 2026Pooled it
- Trial
- The health status of incarcerated people in Canada: a narrative review.Frontiers in public health · 2026Review
- Recognising the heterogeneity of Indigenous Peoples during the COVID-19 pandemic: a scoping review across Canada, Australia, New Zealand and the USA.BMJ public health · 2024Article
- Preparing correctional settings for the next pandemic: a modeling study of COVID-19 outbreaks in two high-income countries.Frontiers in public health · 2024Article
- Understanding the determinants of vaccine hesitancy in the United States: A comparison of social surveys and social media.PloS one · 2024Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Kathryn RomanchukCentre for Outcomes Research and Evaluation (Romanchuk, Linthwaite, Cox, Park, Dussault, Lebouché, Kronfli), Research Institute of the McGill University Health Centre; Department of Epidemiology, Biostatistics and Occupational Health (Cox, Basta, Kronfli), School of Population and Global Health, McGill University; Department of Medicine (Cox, Lebouché, Kronfli), Division of Infectious Diseases and Chronic Viral Illness Service, McGill University Health Centre, Montréal, Que.; Correctional Service Canada (Varsaneux, Worthington), Ottawa, Ont.; Department of Family Medicine (Lebouché), McGill University, Montréal, Que.; Faculty of Nursing (MacDonald), University of Alberta; School of Public Health (MacDonald), University of Alberta, Edmonton, Alta.; Division of Immunization Programs and Pandemic Preparedness (Ismail), Centre for Immunization and Respiratory Infectious Diseases, Public Health Agency of Canada and Metro City Medical Clinic, Ottawa, Ont.
Blake LinthwaiteCentre for Outcomes Research and Evaluation (Romanchuk, Linthwaite, Cox, Park, Dussault, Lebouché, Kronfli), Research Institute of the McGill University Health Centre; Department of Epidemiology, Biostatistics and Occupational Health (Cox, Basta, Kronfli), School of Population and Global Health, McGill University; Department of Medicine (Cox, Lebouché, Kronfli), Division of Infectious Diseases and Chronic Viral Illness Service, McGill University Health Centre, Montréal, Que.; Correctional Service Canada (Varsaneux, Worthington), Ottawa, Ont.; Department of Family Medicine (Lebouché), McGill University, Montréal, Que.; Faculty of Nursing (MacDonald), University of Alberta; School of Public Health (MacDonald), University of Alberta, Edmonton, Alta.; Division of Immunization Programs and Pandemic Preparedness (Ismail), Centre for Immunization and Respiratory Infectious Diseases, Public Health Agency of Canada and Metro City Medical Clinic, Ottawa, Ont.
Joseph CoxCentre for Outcomes Research and Evaluation (Romanchuk, Linthwaite, Cox, Park, Dussault, Lebouché, Kronfli), Research Institute of the McGill University Health Centre; Department of Epidemiology, Biostatistics and Occupational Health (Cox, Basta, Kronfli), School of Population and Global Health, McGill University; Department of Medicine (Cox, Lebouché, Kronfli), Division of Infectious Diseases and Chronic Viral Illness Service, McGill University Health Centre, Montréal, Que.; Correctional Service Canada (Varsaneux, Worthington), Ottawa, Ont.; Department of Family Medicine (Lebouché), McGill University, Montréal, Que.; Faculty of Nursing (MacDonald), University of Alberta; School of Public Health (MacDonald), University of Alberta, Edmonton, Alta.; Division of Immunization Programs and Pandemic Preparedness (Ismail), Centre for Immunization and Respiratory Infectious Diseases, Public Health Agency of Canada and Metro City Medical Clinic, Ottawa, Ont.
Hyejin ParkCentre for Outcomes Research and Evaluation (Romanchuk, Linthwaite, Cox, Park, Dussault, Lebouché, Kronfli), Research Institute of the McGill University Health Centre; Department of Epidemiology, Biostatistics and Occupational Health (Cox, Basta, Kronfli), School of Population and Global Health, McGill University; Department of Medicine (Cox, Lebouché, Kronfli), Division of Infectious Diseases and Chronic Viral Illness Service, McGill University Health Centre, Montréal, Que.; Correctional Service Canada (Varsaneux, Worthington), Ottawa, Ont.; Department of Family Medicine (Lebouché), McGill University, Montréal, Que.; Faculty of Nursing (MacDonald), University of Alberta; School of Public Health (MacDonald), University of Alberta, Edmonton, Alta.; Division of Immunization Programs and Pandemic Preparedness (Ismail), Centre for Immunization and Respiratory Infectious Diseases, Public Health Agency of Canada and Metro City Medical Clinic, Ottawa, Ont.
Camille DussaultCentre for Outcomes Research and Evaluation (Romanchuk, Linthwaite, Cox, Park, Dussault, Lebouché, Kronfli), Research Institute of the McGill University Health Centre; Department of Epidemiology, Biostatistics and Occupational Health (Cox, Basta, Kronfli), School of Population and Global Health, McGill University; Department of Medicine (Cox, Lebouché, Kronfli), Division of Infectious Diseases and Chronic Viral Illness Service, McGill University Health Centre, Montréal, Que.; Correctional Service Canada (Varsaneux, Worthington), Ottawa, Ont.; Department of Family Medicine (Lebouché), McGill University, Montréal, Que.; Faculty of Nursing (MacDonald), University of Alberta; School of Public Health (MacDonald), University of Alberta, Edmonton, Alta.; Division of Immunization Programs and Pandemic Preparedness (Ismail), Centre for Immunization and Respiratory Infectious Diseases, Public Health Agency of Canada and Metro City Medical Clinic, Ottawa, Ont.
Nicole E BastaCentre for Outcomes Research and Evaluation (Romanchuk, Linthwaite, Cox, Park, Dussault, Lebouché, Kronfli), Research Institute of the McGill University Health Centre; Department of Epidemiology, Biostatistics and Occupational Health (Cox, Basta, Kronfli), School of Population and Global Health, McGill University; Department of Medicine (Cox, Lebouché, Kronfli), Division of Infectious Diseases and Chronic Viral Illness Service, McGill University Health Centre, Montréal, Que.; Correctional Service Canada (Varsaneux, Worthington), Ottawa, Ont.; Department of Family Medicine (Lebouché), McGill University, Montréal, Que.; Faculty of Nursing (MacDonald), University of Alberta; School of Public Health (MacDonald), University of Alberta, Edmonton, Alta.; Division of Immunization Programs and Pandemic Preparedness (Ismail), Centre for Immunization and Respiratory Infectious Diseases, Public Health Agency of Canada and Metro City Medical Clinic, Ottawa, Ont.
Olivia VarsaneuxCentre for Outcomes Research and Evaluation (Romanchuk, Linthwaite, Cox, Park, Dussault, Lebouché, Kronfli), Research Institute of the McGill University Health Centre; Department of Epidemiology, Biostatistics and Occupational Health (Cox, Basta, Kronfli), School of Population and Global Health, McGill University; Department of Medicine (Cox, Lebouché, Kronfli), Division of Infectious Diseases and Chronic Viral Illness Service, McGill University Health Centre, Montréal, Que.; Correctional Service Canada (Varsaneux, Worthington), Ottawa, Ont.; Department of Family Medicine (Lebouché), McGill University, Montréal, Que.; Faculty of Nursing (MacDonald), University of Alberta; School of Public Health (MacDonald), University of Alberta, Edmonton, Alta.; Division of Immunization Programs and Pandemic Preparedness (Ismail), Centre for Immunization and Respiratory Infectious Diseases, Public Health Agency of Canada and Metro City Medical Clinic, Ottawa, Ont.
James WorthingtonCentre for Outcomes Research and Evaluation (Romanchuk, Linthwaite, Cox, Park, Dussault, Lebouché, Kronfli), Research Institute of the McGill University Health Centre; Department of Epidemiology, Biostatistics and Occupational Health (Cox, Basta, Kronfli), School of Population and Global Health, McGill University; Department of Medicine (Cox, Lebouché, Kronfli), Division of Infectious Diseases and Chronic Viral Illness Service, McGill University Health Centre, Montréal, Que.; Correctional Service Canada (Varsaneux, Worthington), Ottawa, Ont.; Department of Family Medicine (Lebouché), McGill University, Montréal, Que.; Faculty of Nursing (MacDonald), University of Alberta; School of Public Health (MacDonald), University of Alberta, Edmonton, Alta.; Division of Immunization Programs and Pandemic Preparedness (Ismail), Centre for Immunization and Respiratory Infectious Diseases, Public Health Agency of Canada and Metro City Medical Clinic, Ottawa, Ont.
Bertrand LebouchéCentre for Outcomes Research and Evaluation (Romanchuk, Linthwaite, Cox, Park, Dussault, Lebouché, Kronfli), Research Institute of the McGill University Health Centre; Department of Epidemiology, Biostatistics and Occupational Health (Cox, Basta, Kronfli), School of Population and Global Health, McGill University; Department of Medicine (Cox, Lebouché, Kronfli), Division of Infectious Diseases and Chronic Viral Illness Service, McGill University Health Centre, Montréal, Que.; Correctional Service Canada (Varsaneux, Worthington), Ottawa, Ont.; Department of Family Medicine (Lebouché), McGill University, Montréal, Que.; Faculty of Nursing (MacDonald), University of Alberta; School of Public Health (MacDonald), University of Alberta, Edmonton, Alta.; Division of Immunization Programs and Pandemic Preparedness (Ismail), Centre for Immunization and Respiratory Infectious Diseases, Public Health Agency of Canada and Metro City Medical Clinic, Ottawa, Ont.
Shannon E MacDonaldCentre for Outcomes Research and Evaluation (Romanchuk, Linthwaite, Cox, Park, Dussault, Lebouché, Kronfli), Research Institute of the McGill University Health Centre; Department of Epidemiology, Biostatistics and Occupational Health (Cox, Basta, Kronfli), School of Population and Global Health, McGill University; Department of Medicine (Cox, Lebouché, Kronfli), Division of Infectious Diseases and Chronic Viral Illness Service, McGill University Health Centre, Montréal, Que.; Correctional Service Canada (Varsaneux, Worthington), Ottawa, Ont.; Department of Family Medicine (Lebouché), McGill University, Montréal, Que.; Faculty of Nursing (MacDonald), University of Alberta; School of Public Health (MacDonald), University of Alberta, Edmonton, Alta.; Division of Immunization Programs and Pandemic Preparedness (Ismail), Centre for Immunization and Respiratory Infectious Diseases, Public Health Agency of Canada and Metro City Medical Clinic, Ottawa, Ont.
Shainoor J IsmailCentre for Outcomes Research and Evaluation (Romanchuk, Linthwaite, Cox, Park, Dussault, Lebouché, Kronfli), Research Institute of the McGill University Health Centre; Department of Epidemiology, Biostatistics and Occupational Health (Cox, Basta, Kronfli), School of Population and Global Health, McGill University; Department of Medicine (Cox, Lebouché, Kronfli), Division of Infectious Diseases and Chronic Viral Illness Service, McGill University Health Centre, Montréal, Que.; Correctional Service Canada (Varsaneux, Worthington), Ottawa, Ont.; Department of Family Medicine (Lebouché), McGill University, Montréal, Que.; Faculty of Nursing (MacDonald), University of Alberta; School of Public Health (MacDonald), University of Alberta, Edmonton, Alta.; Division of Immunization Programs and Pandemic Preparedness (Ismail), Centre for Immunization and Respiratory Infectious Diseases, Public Health Agency of Canada and Metro City Medical Clinic, Ottawa, Ont.
Nadine KronfliCentre for Outcomes Research and Evaluation (Romanchuk, Linthwaite, Cox, Park, Dussault, Lebouché, Kronfli), Research Institute of the McGill University Health Centre; Department of Epidemiology, Biostatistics and Occupational Health (Cox, Basta, Kronfli), School of Population and Global Health, McGill University; Department of Medicine (Cox, Lebouché, Kronfli), Division of Infectious Diseases and Chronic Viral Illness Service, McGill University Health Centre, Montréal, Que.; Correctional Service Canada (Varsaneux, Worthington), Ottawa, Ont.; Department of Family Medicine (Lebouché), McGill University, Montréal, Que.; Faculty of Nursing (MacDonald), University of Alberta; School of Public Health (MacDonald), University of Alberta, Edmonton, Alta.; Division of Immunization Programs and Pandemic Preparedness (Ismail), Centre for Immunization and Respiratory Infectious Diseases, Public Health Agency of Canada and Metro City Medical Clinic, Ottawa, Ont. nadine.kronfli@mcgill.ca.
Funding
CIHR
Abstract
backgroundMaximizing uptake of SARS-CoV-2 vaccines among people in prison is essential in mitigating future outbreaks. We aimed to determine factors associated with willingness to receive SARS-CoV-2 vaccination before vaccine availability.
methodsWe chose 3 Canadian federal prisons based on their low uptake of influenza vaccines in 2019-2020. Participants completed a self-administered questionnaire on knowledge, attitude and beliefs toward vaccines. The primary outcome was participant willingness to receive a SARS-CoV-2 vaccine, measured using a 5-point Likert scale to the question, "If a safe and effective COVID-19 vaccine becomes available in prison, how likely are you to get vaccinated?" We calculated the association of independent variables (age, ethnicity, chronic health conditions, 2019-2020 influenza vaccine uptake and prison security level), identified a priori, with vaccine willingness using logistic regression and crude and adjusted odds ratios (ORs) with 95% confidence intervals (CIs).
resultsWe recruited 240 participants from Mar. 31 to Apr. 19, 2021 (median age 46 years; 19.2% female, 25.8% Indigenous). Of these, 178 (74.2%) were very willing to receive a SARS-CoV-2 vaccine. Participants who received the 2019-2020 influenza vaccine (adjusted OR 5.20, 95% CI 2.43-12.00) had higher odds of vaccine willingness than those who did not; those who self-identified as Indigenous (adjusted OR 0.27, 95% CI 0.11-0.60) and in medium- or maximum-security prisons (adjusted OR 0.36, 95% CI 0.12-0.92) had lower odds of vaccine willingness than those who identified as white or those in minimum-security prisons, respectively.
interpretationMost participants were very willing to receive vaccination against SARS-CoV-2 before vaccine roll-out. Vaccine promotion campaigns should target groups with low vaccine willingness (i.e., those who have declined influenza vaccine, identify as Indigenous or reside in high-security prisons).
Indexed as
COVID-19Influenza, HumanInfluenza VaccinesPrisonersCanadaCOVID-19 VaccinesCross-Sectional StudiesFemaleHumansMaleMiddle AgedPrisonsSARS-CoV-2COVID-19 VaccinesInfluenza Vaccines
Identifiers
What OpenQuestion holds
Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.